Minerva Surgical, Inc. Common Stock
UTRS
UTRS was delisted on the 28th of December, 2023.
20 hedge funds and large institutions have $3.6M invested in Minerva Surgical, Inc. Common Stock in 2022 Q4 according to their latest regulatory filings, with 6 funds opening new positions, 2 increasing their positions, 4 reducing their positions, and 6 closing their positions.
0% more funds holding
Funds holding: 20 → 20 (0)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
0% more first-time investments, than exits
New positions opened: 6 | Existing positions closed: 6
50% less repeat investments, than reductions
Existing positions increased: 2 | Existing positions reduced: 4
88% less capital invested
Capital invested by funds: $31.2M → $3.6M (-$27.6M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AIC
AWM Investment Company
New York
|
+$93K |
| 2 |
UBS Group
Zurich,
Switzerland
|
+$13.3K |
| 3 |
VF
Virtu Financial
New York
|
+$9.64K |
| 4 |
Morgan Stanley
New York
|
+$8.64K |
| 5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$6.29K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
NHAS
Novo Holdings A/S
Hellerup,
Denmark
|
-$17.2M |
| 2 |
LM
Luminus Management
Houston,
Texas
|
-$794K |
| 3 |
Fidelity Investments
Boston,
Massachusetts
|
-$179K |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
-$131K |
| 5 |
LNWTC
Laird Norton Wetherby Trust Company
Seattle,
Washington
|
-$104K |
UTRS Hedge Fund Activity: Q4 2022 in Review
20 of the 6,222 institutional investors tracked by Wall St. Rank reported a position in Minerva Surgical, Inc. Common Stock (UTRS) for Q4 2022, worth a combined $3.6M — down 88% from $31.2M a quarter earlier.
Fund positioning in UTRS was balanced in Q4 2022: 6 funds opened new positions, 6 closed out, 2 added to existing stakes and 4 trimmed.
The largest buyer was AWM Investment Company, adding an estimated $93K. The largest seller was Novo Holdings A/S, exiting entirely with an estimated $17.2M sold.
- 20 institutional investors held Minerva Surgical, Inc. Common Stock (UTRS) as of Q4 2022, unchanged from Q3 2022.
- Funds reported $3.6M of Minerva Surgical, Inc. Common Stock stock for Q4 2022, down 88% quarter-over-quarter.
- 6 funds opened new Minerva Surgical, Inc. Common Stock positions in Q4 2022 and 6 closed out, a net change of 0 holders.
- The largest Minerva Surgical, Inc. Common Stock buyer in Q4 2022 was AWM Investment Company, an estimated $93K added.
- The largest Minerva Surgical, Inc. Common Stock seller in Q4 2022 was Novo Holdings A/S, an estimated $17.2M sold.
Based on aggregated 13F filings for Q4 2022.